LifeMD, Inc. (LFMD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Core Viewpoint - Investors in LifeMD, Inc. have the opportunity to lead a securities fraud class action lawsuit due to substantial losses incurred as a result of misleading statements made by the company's management regarding its competitive position and financial guidance [1][3]. Group 1: Lawsuit Details - The lawsuit alleges that from May 7, 2025, to August 5, 2025, LifeMD's management materially overstated the company's competitive position [3]. - It is claimed that the management was reckless in raising LifeMD's 2025 guidance without properly accounting for rising customer acquisition costs in its RexMD segment and related to obesity treatment drugs [3]. - The positive statements made by the defendants about LifeMD's business operations and prospects were materially misleading and lacked a reasonable basis during the relevant period [3]. Group 2: Participation Information - Investors who suffered losses in LifeMD, Inc. are encouraged to contact the Law Offices of Howard G. Smith before October 27, 2025, to participate in the ongoing lawsuit [2][4]. - Interested parties can reach out via email, telephone, or visit the law firm's website for more information regarding their legal rights [2][4].